Trial Profile
Study for predictors of response to infliximab therapy for ulcerative colitis.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 13 May 2016
Price :
$35
*
At a glance
- Drugs Infliximab (Primary)
- Indications Ulcerative colitis
- Focus Therapeutic Use
- 11 Feb 2012 New trial record